These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12874021)

  • 21. Utilizing quantitative polymerase chain reaction to evaluate prostate stem cell antigen as a tumor marker in pancreatic cancer.
    Grubbs EG; Abdel-Wahab Z; Tyler DS; Pruitt SK
    Ann Surg Oncol; 2006 Dec; 13(12):1645-54. PubMed ID: 16957968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene cloning of immunogenic antigens overexpressed in pancreatic cancer.
    Nakatsura T; Senju S; Yamada K; Jotsuka T; Ogawa M; Nishimura Y
    Biochem Biophys Res Commun; 2001 Mar; 281(4):936-44. PubMed ID: 11237751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes].
    Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH
    Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling.
    Sato N; Fukushima N; Matsubayashi H; Goggins M
    Oncogene; 2004 Feb; 23(8):1531-8. PubMed ID: 14716296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer.
    Koide N; Yamada T; Shibata R; Mori T; Fukuma M; Yamazaki K; Aiura K; Shimazu M; Hirohashi S; Nimura Y; Sakamoto M
    Clin Cancer Res; 2006 Apr; 12(8):2419-26. PubMed ID: 16638847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation.
    Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC
    Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer.
    Zhang ML; Lu S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):313-7. PubMed ID: 18522889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential gene expression in patients genetically predisposed to pancreatic cancer.
    Zervos EE; Tanner SM; Osborne DA; Bloomston M; Rosemurgy AS; Ellison EC; Melvin WS; de la Chapelle A
    J Surg Res; 2006 Oct; 135(2):317-22. PubMed ID: 16815451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.
    Kayed H; Kleeff J; Esposito I; Giese T; Keleg S; Giese N; Büchler MW; Friess H
    Mol Carcinog; 2005 Apr; 42(4):183-92. PubMed ID: 15754313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation of the ASC gene promoter is associated with aggressive prostate cancer.
    Collard RL; Harya NS; Monzon FA; Maier CE; O'Keefe DS
    Prostate; 2006 May; 66(7):687-95. PubMed ID: 16425203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E-cadherin and DAP kinase in pancreatic adenocarcinoma and corresponding lymph node metastases.
    Dansranjavin T; Möbius C; Tannapfel A; Bartels M; Wittekind C; Hauss J; Witzigmann H
    Oncol Rep; 2006 May; 15(5):1125-31. PubMed ID: 16596173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
    Matsubayashi H; Sato N; Fukushima N; Yeo CJ; Walter KM; Brune K; Sahin F; Hruban RH; Goggins M
    Clin Cancer Res; 2003 Apr; 9(4):1446-52. PubMed ID: 12684418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic inactivation of TFPI-2 as a common mechanism associated with growth and invasion of pancreatic ductal adenocarcinoma.
    Sato N; Parker AR; Fukushima N; Miyagi Y; Iacobuzio-Donahue CA; Eshleman JR; Goggins M
    Oncogene; 2005 Jan; 24(5):850-8. PubMed ID: 15592528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
    Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
    Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines.
    Wada M; Yazumi S; Takaishi S; Hasegawa K; Sawada M; Tanaka H; Ida H; Sakakura C; Ito K; Ito Y; Chiba T
    Oncogene; 2004 Mar; 23(13):2401-7. PubMed ID: 14743205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
    Ueki T; Toyota M; Skinner H; Walter KM; Yeo CJ; Issa JP; Hruban RH; Goggins M
    Cancer Res; 2001 Dec; 61(23):8540-6. PubMed ID: 11731440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.